Unknown

Dataset Information

0

Recessive osteogenesis imperfecta caused by missense mutations in SPARC.

ABSTRACT: Secreted protein, acidic, cysteine-rich (SPARC) is a glycoprotein that binds to collagen type I and other proteins in the extracellular matrix. Using whole-exome sequencing to identify the molecular defect in two unrelated girls with severe bone fragility and a clinical diagnosis of osteogenesis imperfecta type IV, we identified two homozygous variants in SPARC (GenBank: NM_003118.3; c.497G>A [p.Arg166His] in individual 1; c.787G>A [p.Glu263Lys] in individual 2). Published modeling and site-directed mutagenesis studies had previously shown that the residues substituted by these mutations form an intramolecular salt bridge in SPARC and are essential for the binding of SPARC to collagen type I. The amount of SPARC secreted by skin fibroblasts was reduced in individual 1 but appeared normal in individual 2. The migration of collagen type I alpha chains produced by these fibroblasts was mildly delayed on SDS-PAGE gel, suggesting some overmodification of collagen during triple helical formation. Pulse-chase experiments showed that collagen type I secretion was mildly delayed in skin fibroblasts from both individuals. Analysis of an iliac bone sample from individual 2 showed that trabecular bone was hypermineralized on the material level. In conclusion, these observations show that homozygous mutations in SPARC can give rise to severe bone fragility in humans.

SUBMITTER: Mendoza-Londono R 

PROVIDER: S-EPMC4457955 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Secreted protein, acidic, cysteine-rich (SPARC) is a glycoprotein that binds to collagen type I and other proteins in the extracellular matrix. Using whole-exome sequencing to identify the molecular defect in two unrelated girls with severe bone fragility and a clinical diagnosis of osteogenesis imperfecta type IV, we identified two homozygous variants in SPARC (GenBank: NM_003118.3; c.497G>A [p.Arg166His] in individual 1; c.787G>A [p.Glu263Lys] in individual 2). Published modeling and site-dire  ...[more]

Similar Datasets

Unknown CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta.
| S-EPMC2671575 | biostudies-literature
Unknown Autosomal-Recessive Mutations in MESD Cause Osteogenesis Imperfecta.
| S-EPMC6817720 | biostudies-literature
Unknown Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome.
| S-EPMC3179293 | biostudies-literature
Unknown Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta.
| S-EPMC3156555 | biostudies-literature
Unknown Variable brain phenotype primarily affects the brainstem and cerebellum in patients with osteogenesis imperfecta caused by recessive WNT1 mutations.
| S-EPMC4898782 | biostudies-literature
Unknown Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta.
| S-EPMC3059418 | biostudies-literature
Unknown WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta.
| S-EPMC3617391 | biostudies-literature
Unknown Novel mutations in BMP1 result in a patient with autosomal recessive osteogenesis imperfecta.
| S-EPMC8222833 | biostudies-literature
Unknown Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta.
| S-EPMC2850430 | biostudies-literature
Unknown Novel Compound Heterozygous Mutations in <i>CRTAP</i> Cause Rare Autosomal Recessive Osteogenesis Imperfecta.
| S-EPMC7457090 | biostudies-literature